Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bamias

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2006
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapyE Kastritis, E Efstathiou, D Gika, et al.
European Journal of Gynaecological Oncology|August 27, 2005
Late relapse of epithelial ovarian cancer: a single institution experienceA Bamias, E Efstathiou, M Vassilakopoulou, et al.
European Journal of Gynaecological Oncology|January 10, 2006
Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterusG T Bozas, A Bamias, E Kastritis, et al.
Oncology|February 5, 2003
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology GroupA Bamias, G Aravantinos, C Kalofonos, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1E Anagnostaki, D Skarlos, N Tamvakis, et al.
Urology|January 26, 2005
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessmentE Efstathiou, G Bozas, A Kostakopoulos, et al.
Gynecologic Oncology|October 13, 2006
The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapyE Kastritis, A Bamias, G Bozas, et al.
Gynecologic Oncology|July 19, 2011
Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experienceA Bamias, A Karadimou, N Soupos, et al.
Urology|August 2, 2003
Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinomaA Bamias, M Chorti, C Deliveliotis, et al.
Leukemia & Lymphoma|February 28, 2007
Renal failure in multiple myeloma: incidence, correlations, and prognostic significanceV Eleutherakis-Papaiakovou, A Bamias, D Gika, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2006
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapyE Kastritis, E Efstathiou, D Gika, et al.
European Journal of Gynaecological Oncology|August 27, 2005
Late relapse of epithelial ovarian cancer: a single institution experienceA Bamias, E Efstathiou, M Vassilakopoulou, et al.
European Journal of Gynaecological Oncology|January 10, 2006
Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterusG T Bozas, A Bamias, E Kastritis, et al.
Oncology|February 5, 2003
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology GroupA Bamias, G Aravantinos, C Kalofonos, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1E Anagnostaki, D Skarlos, N Tamvakis, et al.
Urology|January 26, 2005
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessmentE Efstathiou, G Bozas, A Kostakopoulos, et al.
Gynecologic Oncology|October 13, 2006
The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapyE Kastritis, A Bamias, G Bozas, et al.
Gynecologic Oncology|July 19, 2011
Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experienceA Bamias, A Karadimou, N Soupos, et al.
Urology|August 2, 2003
Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinomaA Bamias, M Chorti, C Deliveliotis, et al.
Leukemia & Lymphoma|February 28, 2007
Renal failure in multiple myeloma: incidence, correlations, and prognostic significanceV Eleutherakis-Papaiakovou, A Bamias, D Gika, et al.
Pageof 9